Skip to main content

PLEASE NOTE: For everyone’s safety, Fasken recommends anyone on-site at our Canadian offices be familiar with the COVID-19 recommendations in place which may include one or more of the following: social distancing, hand sanitizing, wearing a mask in common areas and proof of full vaccination. These measures apply to lawyers, staff, clients, service providers and other visitors.

Sylvie Bourdeau associée/partner Montréal

Sylvie Bourdeau

Partner | Co-leader, Life Sciences Fasken
Assessing the risks associated with a business transaction and the solutions put forward to properly allocate, control or mitigate them is a key element of its success.
Jurisdiction Quebec, 1988
Language(s) French, English
Office(s) Montréal


Sylvie Bourdeau specializes in business and mergers and acquisition law.  Over the years she has been involved in numerous mandates involving the financial products and services and life sciences/pharmaceuticals industries.

In addition to the numerous mergers and acquisitions and private financings mandates in which she has been involved in her practice, Sylvie’s also represented many clients in matters involving the drafting of complex commercial agreements, including  for joint ventures, franchises, collaboration agreements, outsourcing of services, licensing, distribution, manufacturing and limited partnerships.

Sylvie has acquired extensive expertise in the regulations governing financial institutions (insurers, trust companies and deposit institutions) and advises many of them on a regular basis with respect to the regulations applicable in Canada and Québec. She counsels clients in connection with the creation of new financial institutions, reinsurance, rules governing investments and capital management, compliance, development of new products, consumer protection and the contracts and operations related to their activities. Her experience in the regulation of financial institutions, combined with her expertise in business law, make her a trusted resource for the “Fin Tech” industry in general. Sylvie also assists clients in their dealings with the competent regulatory authorities.

Sylvie is co-leader of the national Life Sciences Practice Group and advises a number of clients in the life sciences and pharmaceutical industries on commercial operations of all kinds and on issues related to the legislation of the health sector applicable in Québec.


Client Work

Date Client

Career & Education


  • LLB Université de Montréal

Community involvement


  • Member of the Board of Directors and Chair of the Ethics Committee of the Commission administrative des régimes de retraite et d'assurances (CARRA) (2009 to 2015)
  • Member of the Board of Directors of Valeo Corporation Inc. (2010 to 2021)
  • Member of the Board of Directors and Chair of the Ethics Committee, YWCA Montreal (2013 to 2019)
  • Member of the Board of Directors of Leucan (2008 to 2010)

Memberships & Affiliations

  • Member, Canadian Bar Association
  • Member, Québec Bar
  • Member, Bar of Montréal
  • Member, Réseau Capital
  • Member, Association of Québec Women in Finance


Fasken Institute



Article The Canadian Insurance M&A Environment Asian-Mena Counsel M&A Special Report
Newsletter Life Line Life Sciences Newsletter

Speaking Engagements

The Framework Essentials of Fintech in Canada (Les essentiels de l’encadrement des FINTECH au Canada) Presented at the Journée stratégique sur les enjeux juridiques et d'affaires des fintechs organized by Open Forum Ouvert location location Montreal Hotel Omni Mont-Royal
Fintechs: What are the legal issues? Presented at the the conference on Recent Developments in Banking Law organized by the Continuing Education of the Barreau du Québec.


    Receive email updates from our team